Life Biosciences is a biotechnology company focused on aging biology and cellular rejuvenation therapies. The company is developing a partial epigenetic reprogramming platform to reverse and prevent multiple diseases of aging, with the aim of extending healthy human lifespan. They highlight groundbreaking research in aging biology, including connections to Shinya Yamanaka’s Nobel-prize winning work. Life Biosciences operates in the biomedical field, targeting aging-related diseases and aging processes to improve healthspan.
No recent news for this company.
No recent deals for this company.